Medtronic Launches Dual-Channel Pain Reliever, Buys Certain Elekta Assets
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's Synergy dual-channel neurostimulation system for chronic intractable pain of the trunk and limbs is expected to account for roughly 25% of the company's neurostimulation business following its U.S. rollout Nov. 22, Medtronic says.